PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.92%
Positive revenue growth while MTDR is negative. John Neff might see a notable competitive edge here.
1.42%
Positive gross profit growth while MTDR is negative. John Neff would see a clear operational edge over the competitor.
-0.43%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.43%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-57.44%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-58.54%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-58.75%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
3.43%
Slight or no buybacks while MTDR is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
2.60%
Slight or no buyback while MTDR is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
9.96%
Dividend growth above 1.5x MTDR's 0.08%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-2.22%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
12.87%
Positive FCF growth while MTDR is negative. John Neff would see a strong competitive edge in net cash generation.
-38.83%
Negative 10Y revenue/share CAGR while MTDR stands at 690.14%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-38.83%
Negative 5Y CAGR while MTDR stands at 1272.50%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-38.83%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-60.55%
Negative 10Y net income/share CAGR while MTDR is at 163.75%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-60.55%
Negative 5Y net income/share CAGR while MTDR is 139.65%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-60.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
79.25%
Below 50% of MTDR's 274.37%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
79.25%
Below 50% of MTDR's 204.54%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
79.25%
3Y equity/share CAGR at 75-90% of MTDR's 101.40%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.74%
AR growth well above MTDR's 2.38%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.08%
Inventory is declining while MTDR stands at 23.07%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.20%
Negative asset growth while MTDR invests at 1.79%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-4.89%
We have a declining book value while MTDR shows 2.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
6.65%
Debt growth far above MTDR's 0.54%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
6.86%
We expand SG&A while MTDR cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.